The researchers say that, to their knowledge, this is the first demonstration of programmable, site-specific integration of a ...

For years, one of the most powerful weapons against certain blood cancers, called CAR-T cell therapy, has required an ...

HCW Biologics Inc. (NASDAQ:HCWB) announced new research published in Science Advances indicating that its compound HCW9206 ...

Researchers at UC San Francisco have now developed a way to reprogram these cancer-fighting cells directly inside the body. This new method could remove the need for external manufacturing, ...

CAR T-cell therapy is a personalized treatment that uses a patient’s own immune cells to fight cancer, making it effective but unsuitable for mass production, which increases the cost. The complex ...

A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells that dramatically prolongs their effectiveness after being infused into ...

Avantor AVTR recently entered into a strategic partnership with BlueWhale Bio to accelerate innovation in CAR-T cell therapy manufacturing. The collaboration merges Avantor’s bioprocessing expertise ...

A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells ...

The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of ...

AI automation, and more skilled staff are needed to ensure cancer patients can access potentially life-saving CAR T therapies.

Pharmaceutical companies are shifting from the development of autologous cell therapies to allogeneic cell therapies.